News
Hosted on MSN8mon
GSK pumps up to $800m for US manufacturing site upgrade - MSNThe funding, which brings GSK’s expenditure in US manufacturing capabilities close to $1.3bn, will establish a new vaccines drug substance facility and an R&D pilot plant.
Big Pharma firm GSK plans to invest up to $800 million to expand its manufacturing operations in Pennsylvania and create 200 new jobs.
GSK plans to invest $800 million in its East Donegal Township vaccine packaging facility over the next four years in an expansion project ... The MAPS facility is expected to be completed ...
Additionally, GSK will establish a new vaccines drug substance facility at the site, dedicated to manufacturing products based on the company’s novel MAPS technology, subsequent to future ...
The centrepiece of the new investment is a multi-purpose facility capable of manufacturing sterile liquid vaccines and medicines, for which GSK says there is "ever increasing demand," and a ...
GSK invested up to $800 million to expand its Marietta, Pennsylvania, facility, its largest U.S. manufacturing investment to date, according to an Oct. 24 press release.
MARIETTA, Pa. (WHTM) — A global biopharma company just announced that it will be investing up to $800 million to expand its long-time Lancaster County manufacturing facility. During a press ...
GSK Plc GSK has made an investment of over €250 million ($272 million) in a vaccine facility located in Belgium.. The company plans to construct a new section dedicated to freeze-drying vaccines ...
MARIETTA, Pa. (WHTM) — A global biopharma company just announced that it will be investing up to $800 million to expand its long-time Lancaster County manufacturing facility. During a press c… ...
GSK is laying out €250 million to bolster vaccine manufacturing with a new facility to help make free-dried shots, including for shingles and RSV.
Roger Connor, president of GSK vaccines, said: “GSK is delighted to support Novavax and the UK vaccines taskforce with this manufacturing arrangement for the UK and our Barnard Castle facility ...
MARIETTA, Pa. (WHTM) — A global biopharma company just announced that it will be investing up to $800 million to expand its long-time Lancaster County manufacturing facility. During a press ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results